The NHS is hurtling towards the most severe financial shortfall of its history, and faces an austere future of cutting …
Contract research organisation Kendle has opened up new offices in Malaysia, Thailand and the Philippines as part of a continued …
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …
Sanofi-Aventis will pay 30 million euros (£26 million) for a manufacturing plant in Germany operated by Pfizer in a deal …
The Pharmaceutical Marketing Society is to showcase the best in digital media across the pharma and healthcare industry at a …
GlaxoSmithKline has chosen new agencies to handle some of it biggest consumer brands, including Nicorette and weight loss drug Alli. …
Market Research and analytics is an area which continues to present new challenges and opportunities for our industry. I first …
Andy Burnham has been named as the government's new secretary of state for health, in Prime Minister Gordon Brown's latest …
AstraZeneca is putting more than £4 million over the next three years into an oncology research project with two partners. …
The funding crisis which is paralysing the global biotech sector sees no sign of abating, and more and more companies …
The former managing director of GCI Health has set up a communications agency aimed at pharma companies and other healthcare …
People from across the industry are being asked to volunteer as 'ambassadors' for the pharma sector to conduct a large-scale …
Funding worth £2 million has been made available for research into how NICE can better do its job. The drug …
Since 2000, the top 15 pharmaceutical companies have lost around $800 billion in shareholder value, and looking forward, drug patent …
Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …
Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …
The US medicines regulator is to boost the transparency around its decision-making, in connection with President Obama's aim to make …
Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …